MedTrace Logo

A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads

NCT02525627 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-02-22

Study results available
· View outcomes & findings →

Summary

Prospective, single centre, randomized clinical study; series of patients with a 5-years patient evaluation period.

Conditions

  • Arthroplasty, Replacement, Hip

Interventions

DEVICE

Trident cup, X3 inserts, 28 mm head

Orthopaedic implant

DEVICE

Trident cup, X3 inserts, 40 mm head

Orthopaedic implant

DEVICE

Symax stem

Orthopaedic implant

DEVICE

Accolade TMZF stem

Orthopaedic implant

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Ide C. Heyligers, MD · Atrium Medical Center, Heerlen, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2016-01-12
Completion
2016-01-12

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02525627 on ClinicalTrials.gov